My NCBISign In
Induction of revertant fibres in the mdx mouse using antisense oligonucleotides
Abbie M Fall, Russell Johnsen, Kaite Honeyman, Pat Iversen, Susan Fletcher, Stephen D Wilton
Genet Vaccines Ther. 2006; 4: 3. Published online 2006 May 24. doi: 10.1186/1479-0556-4-3
PMCID:
PMC1481566
Abstract Full Text PDF–1.4M

Is Cited by the Following 9 Articles in this Archive:

Antisense mediated exon skipping therapy for duchenne muscular dystrophy (DMD)
Camilla Brolin, Takehiko Shiraishi
Artif DNA PNA XNA. 2011 Jan-Mar; 2(1): 6–15. doi: 10.4161/adna.2.1.15425
PMCID:
PMC3116580
Abstract Full Text PDF–333K
Personalized exon skipping strategies to address clustered non-deletion dystrophin mutations
Sarah Forrest, Penny L Meloni, Francesco Muntoni, Jihee Kim, Sue Fletcher, Steve D Wilton
Neuromuscul Disord. Author manuscript; available in PMC 2011 December 1.
Published in final edited form as: Neuromuscul Disord. 2010 December; 20(12): 810–816. doi: 10.1016/j.nmd.2010.07.276
PMCID:
PMC2991584
Abstract Full Text PDF–478K
Dystrophin Isoform Induction In Vivo by Antisense-mediated Alternative Splicing
Sue Fletcher, Abbie M Adams, Russell D Johnsen, Kane Greer, Hong M Moulton, Steve D Wilton
Mol Ther. 2010 June; 18(6): 1218–1223. Published online 2010 March 23. doi: 10.1038/mt.2010.45
PMCID:
PMC2889736
Abstract Full Text PDF–476K
Rational Design of Antisense Oligomers to Induce Dystrophin Exon Skipping
Chalermchai Mitrpant, Abbie M Adams, Penny L Meloni, Francesco Muntoni, Sue Fletcher, Steve D Wilton
Mol Ther. 2009 August; 17(8): 1418–1426. Published online 2009 March 17. doi: 10.1038/mt.2009.49
PMCID:
PMC2835229
Abstract Full Text PDF–283K Supplementary Material
Assessment of the feasibility of exon 45–55 multiexon skipping for duchenne muscular dystrophy
Laura van Vliet, Christa L de Winter, Judith CT van Deutekom, Gert-Jan B van Ommen, Annemieke Aartsma-Rus
BMC Med Genet. 2008; 9: 105. Published online 2008 December 1. doi: 10.1186/1471-2350-9-105
PMCID:
PMC2611974
Abstract Full Text PDF–483K
Dynamics of Co-Transcriptional Pre-mRNA Folding Influences the Induction of Dystrophin Exon Skipping by Antisense Oligonucleotides
Keng Boon Wee, Zacharias Aloysius Dwi Pramono, Jian Li Wang, Karl F. MacDorman, Poh San Lai, Woon Chee Yee
PLoS ONE. 2008; 3(3): e1844. Published online 2008 March 26. doi: 10.1371/journal.pone.0001844
PMCID:
PMC2267000
Abstract Full Text PDF–622K Supplementary Material
Optimizing exon skipping therapies for DMD
T Yokota, W Duddy, T Partridge
Acta Myol. 2007 December; 26(3): 179–184.
PMCID:
PMC2949311
Abstract Full Text PDF–1.1M
Antisense-mediated exon skipping: A versatile tool with therapeutic and research applications
Annemieke Aartsma-Rus, Gert-Jan B. van Ommen
RNA. 2007 October; 13(10): 1609–1624. doi: 10.1261/rna.653607
PMCID:
PMC1986821
Abstract Full Text PDF–459K
Antisense oligonucleotide induced exon skipping and the dystrophin gene transcript: cocktails and chemistries
Abbie M Adams, Penny L Harding, Patrick L Iversen, Catherine Coleman, Sue Fletcher, Steve D Wilton
BMC Mol Biol. 2007; 8: 57. Published online 2007 July 2. doi: 10.1186/1471-2199-8-57
PMCID:
PMC1933433
Abstract Full Text PDF–613K Supplementary Material
You are here: NCBI > Literature > PubMed Central (PMC)
Write to the Help Desk